Phase I randomised trial to evaluate the effects of ISIS CRPRx on CRP levels following an endotoxin challenge in volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2014
At a glance
- Drugs ISIS CRPRx (Primary)
- Indications Atrial fibrillation; Rheumatoid arthritis
- Focus Pharmacodynamics
- 26 Mar 2013 New trial record